Medical Research Press Releases

Advances in Transforming Growth Factor-β Signaling

Advances in Transforming Growth Factor-β Signaling

An article published in Experimental Biology and Medicine (Volume 246, Issue 4, February, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220966296) reports a new mechanism for modulating transforming-growth factor beta (TGF-β) signaling. The study, led by Dr. Thomas Thompson, in the Department of Molecular Genetics, Biochemistry and…

Vladimir Potanin Supports Leading Russian Scientists to Propel Fundamental Research of Human Brain in Russia

Vladimir Potanin Supports Leading Russian Scientists to Propel Fundamental Research of Human Brain in Russia

Vladimir Potanin donated 500 million rubles ($6.7ml) to the groundbreaking project, aimed for creation of smart materials with pre-programmed properties, allowing development of conceptually new technologies. The project envisages the establishment of a brand-new Laboratory of Programmable Functional Materials in…

Not a Normal 20 Year Anniversary for Cmed

Not a Normal 20 Year Anniversary for Cmed

Cmed, a full-service technology-led CRO that specializes in oncology, immuno-oncology, cell and gene therapy and rare diseases is celebrating its 20 year anniversary. These are not normal times and Cmed is not a normal CRO or technology provider. Instead, it…

Large International Study Pinpoints Impact of TP53 Mutations on Blood Cancer Severity

Large International Study Pinpoints Impact of TP53 Mutations on Blood Cancer Severity

The MDS Foundation announces that a large international study led by researchers at Memorial Sloan Kettering finds that having two mutated copies of the TP53 gene, as opposed to a single mutated copy, is associated with worse outcomes in myelodysplastic syndrome and…

Softwave® Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries

Softwave® Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries

SoftWave® Tissue Regeneration Technologies, a disruptive bio-medical device company, announces the beginning of a trial for “Extracorporeal Shock Wave Therapy in Acute Traumatic Complete and Incomplete Cross – Sectional Lesions.” The trial will be sponsored by the Austrian Workers’ Compensation…

Oligonucleotide Therapeutics: New Drugs That Could Stop COVID-19

Oligonucleotide Therapeutics: New Drugs That Could Stop COVID-19

In response to the COVID-19 pandemic, scientists around the world have joined together in applying their skills and technologies to fight this global threat. Some of the most promising technologies to fight the coronavirus are based on a new type…

EyeKor Inc. Expands Its Executive Team

EyeKor Inc. Expands Its Executive Team

Effective immediately, EyeKor Inc. is promoting Nathan Diers to the role of Vice President of Product Development, leading the development efforts for EXCELSIORTM, EyeKor’s cloud-based, FDA 510(k) cleared, clinical trial image management and analysis software. Nathan Diers brings 15+ years…

New Consulting Company MMG Launches With Focus to Help Revitalize Clinical Trials

New Consulting Company MMG Launches With Focus to Help Revitalize Clinical Trials

Working in the clinical trial space is a challenge given a normal situation, but bringing trial goals to fruition has changed from challenging to impossible. The global pandemic has wreaked havoc on clinical trial schedules for the largest of players…

Overcoming Data Collection and System Challenges in Real World Studies, Upcoming Webinar Presented Byr Cmed

Overcoming Data Collection and System Challenges in Real World Studies, Upcoming Webinar Presented Byr Cmed

Cmed Clinical Research Services will present a webinar to discuss key challenges in data collection for Real-World Studies on March 30. The session will focus on strategies and system features to help facilitate data acquisition, as well as ways to…

Gladstone Scientists Funded by NIH to Dive Deep Into ApoE4's Role in Alzheimer's Disease

Gladstone Scientists Funded by NIH to Dive Deep Into ApoE4's Role in Alzheimer's Disease

The story of Alzheimer’s disease is familiar and heartbreaking. As neurons degenerate and die, patients slowly lose their memories, their thinking skills, and ultimately, their ability to perform basic day-to-day tasks. For years, clinical trials investigating potential treatments for Alzheimer’s disease…

New Small Molecule to Treat Alzheimer's Disease and Dravet Syndrome

New Small Molecule to Treat Alzheimer's Disease and Dravet Syndrome

Gladstone researchers, in collaboration with Genentech, a member of the Roche group, have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer’s disease and a rare genetic form of epilepsy known as Dravet syndrome. The small molecule…

Cmed Reaches 20 Years of Zero Downtime for Clinical Database Services

Cmed Reaches 20 Years of Zero Downtime for Clinical Database Services

Cmed Technology announces 20 years of clinical trial software provision and hosting with zero downtime. Encapsia is Cmed’s clinical data suite, designed around a unified clinical database with user-centric apps to support all trial processes and a full cloud architecture.…

European multicentre study – first expectations fulfilled

European multicentre study – first expectations fulfilled

The pathway to a correct diagnosis in epilepsy patients is often very long. Furthermore, approx. 30% of all patients with epilepsy cannot be treated adequately in spite of a variety of medicinal options. The use of technical options for treatment…

Micro-Leads Announces $10M in Funding for Precision Neuromodulation Therapy

Micro-Leads Announces $10M in Funding for Precision Neuromodulation Therapy

​​​​​Micro-Leads Medical, Inc., a clinical neurostimulation startup developing a high-resolution spinal cord stimulation therapy for treating chronic focal pain without opioids, announced today that it was awarded $10 million in therapy development funding. With the funding, Micro-Leads will further develop its…

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of Aging in Humans

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of Aging in Humans

​​Libella Gene Therapeutics, LLC ("Libella") announces an institutional review board (IRB)-approved pay-to-play clinical trial in Colombia (South America) using gene therapy that aims to treat and ultimately cure aging. This could lead to Libella offering the world's only treatment to…

Predicting Alzheimer's Disease-Like Memory Loss Before It Strikes

Predicting Alzheimer's Disease-Like Memory Loss Before It Strikes

For a person with Alzheimer’s disease, there’s no turning back the clock. By the time she begins to experience memory loss and other worrisome signs, cognitive decline has already set in. And decades of clinical trials have failed to produce…

ANANDA Scientific Forms Research Collaboration and License Agreement with Ben-Gurion University for Cannabinoid Products for Topical Applications

ANANDA Scientific Forms Research Collaboration and License Agreement with Ben-Gurion University for Cannabinoid Products for Topical Applications

ANANDA Scientific today announced it has entered into a license and research agreement with BGN Technologies (BGN), the technology transfer company of Ben-Gurion University of the Negev, Israel, to develop and commercialize cannabinoid products for topical applications. The research, which…

Neil Singla, MD, CEO at Lotus Clinical Research, Speaks on Opioid Sparing Outcomes

Neil Singla, MD, CEO at Lotus Clinical Research, Speaks on Opioid Sparing Outcomes

​Lotus Clinical Research announced that Neil Singla, MD, Chief Scientific Officer spoke at Arrowhead’s Pain & Migraine Therapeutics Summit in Washington, D.C. on Sept. 23, 2019. Arrowhead’s Pain & Migraine Therapeutics Summit is the “U.S.’s premier pain conference covering the field…

New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer's Disease

New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer's Disease

​​​​Katerina Akassoglou, Ph.D., senior investigator at Gladstone Institutes, has fundamentally changed the way scientists think of neurological disorders. She made the seminal discovery that blood leaks are toxic to the brain by promoting inflammation and destroying neurons. Her research led the scientific…

Lotus Clinical Research Adopts Veeva Vault CDMS to Improve Efficiency and Speed Study Timelines Across Clinical Teams

Lotus Clinical Research Adopts Veeva Vault CDMS to Improve Efficiency and Speed Study Timelines Across Clinical Teams

​​​​Lotus Clinical Research is pleased to announce that two of its Biometrics team members, Jennifer Nezzer and Andrea Krueger, presented at 2019 Veeva R&D Summit to discuss Lotus’ use of Veeva Vault CDMS, which combines EDC, coding, data cleaning, and…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login